150 related articles for article (PubMed ID: 33610652)
1. Urology Workforce Changes and Implications for Prostate Cancer Care Among Medicare Enrollees.
Marchetti KA; Oerline M; Hollenbeck BK; Kaufman SR; Skolarus TA; Shahinian VB; Caram MEV; Modi PK
Urology; 2021 Sep; 155():77-82. PubMed ID: 33610652
[TBL] [Abstract][Full Text] [Related]
2. Urologist Practice Structure and Spending for Prostate Cancer Care.
Modi PK; Herrel LA; Kaufman SR; Yan P; Borza T; Skolarus TA; Schroeck FR; Hollenbeck BK; Shahinian VB
Urology; 2019 Aug; 130():65-71. PubMed ID: 31029672
[TBL] [Abstract][Full Text] [Related]
3. The Influence of Practice Structure on Urologists' Treatment of Men With Low-Risk Prostate Cancer.
Mitchell JM; Gresenz CR
Med Care; 2022 Sep; 60(9):665-672. PubMed ID: 35880758
[TBL] [Abstract][Full Text] [Related]
4. Physician visits prior to treatment for clinically localized prostate cancer.
Jang TL; Bekelman JE; Liu Y; Bach PB; Basch EM; Elkin EB; Zelefsky MJ; Scardino PT; Begg CB; Schrag D
Arch Intern Med; 2010 Mar; 170(5):440-50. PubMed ID: 20212180
[TBL] [Abstract][Full Text] [Related]
5. Urologist-Level Correlation in the Use of Observation for Low- and High-Risk Prostate Cancer.
Tyson MD; Graves AJ; O'Neil B; Barocas DA; Chang SS; Penson DF; Resnick MJ
JAMA Surg; 2017 Jan; 152(1):27-34. PubMed ID: 27653425
[TBL] [Abstract][Full Text] [Related]
6. Practice-Level Adoption of Conservative Management for Prostate Cancer.
Modi PK; Kaufman SR; Herrel LA; Dupree JM; Luckenbaugh AN; Skolarus TA; Hollenbeck BK; Shahinian VB
J Oncol Pract; 2019 Oct; 15(10):e863-e869. PubMed ID: 31509481
[TBL] [Abstract][Full Text] [Related]
7. Physician variation in management of low-risk prostate cancer: a population-based cohort study.
Hoffman KE; Niu J; Shen Y; Jiang J; Davis JW; Kim J; Kuban DA; Perkins GH; Shah JB; Smith GL; Volk RJ; Buchholz TA; Giordano SH; Smith BD
JAMA Intern Med; 2014 Sep; 174(9):1450-9. PubMed ID: 25023650
[TBL] [Abstract][Full Text] [Related]
8. Variation in Practice Patterns and Reimbursements Between Female and Male Urologists for Medicare Beneficiaries.
Nam CS; Mehta A; Hammett J; Kim FY; Filson CP
JAMA Netw Open; 2019 Aug; 2(8):e198956. PubMed ID: 31397864
[TBL] [Abstract][Full Text] [Related]
9. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer.
Fowler FJ; McNaughton Collins M; Albertsen PC; Zietman A; Elliott DB; Barry MJ
JAMA; 2000 Jun; 283(24):3217-22. PubMed ID: 10866869
[TBL] [Abstract][Full Text] [Related]
10. Analyzing the current practice patterns and views among urologists regarding focal therapy for prostate cancer.
Jain AL; Sidana A; Maruf M; Sugano D; Calio B; Wood BJ; Pinto PA
Urol Oncol; 2019 Mar; 37(3):182.e1-182.e8. PubMed ID: 30522903
[TBL] [Abstract][Full Text] [Related]
11. Urologists reduce overtreatment in prostate cancer.
Das M
Lancet Oncol; 2018 Aug; 19(8):e384. PubMed ID: 29937393
[No Abstract] [Full Text] [Related]
12. Urologist practice divestment from radiation vault ownership and treatment patterns for prostate cancer.
Faraj KS; Kaufman SR; Herrel LA; Maganty A; Oerline MK; Caram MEV; Shahinian VB; Hollenbeck BK
Cancer; 2024 May; 130(9):1609-1617. PubMed ID: 38146764
[TBL] [Abstract][Full Text] [Related]
13. Adoption of Abiraterone and Enzalutamide by Urologists.
Caram MEV; Kaufman SR; Modi PK; Herrel L; Oerline M; Ross R; Skolarus TA; Hollenbeck BK; Shahinian V
Urology; 2019 Sep; 131():176-183. PubMed ID: 31136769
[TBL] [Abstract][Full Text] [Related]
14. United States radiation oncologists' and urologists' opinions about screening and treatment of prostate cancer vary by region.
McNaughton Collins M; Barry MJ; Zietman A; Albertsen PC; Talcott JA; Walker Corkery E; Elliott DB; Fowler FJ
Urology; 2002 Oct; 60(4):628-33. PubMed ID: 12385923
[TBL] [Abstract][Full Text] [Related]
15. Understanding the Role of Urology Practice Organization and Racial Composition in Prostate Cancer Treatment Disparities.
Agochukwu-Mmonu N; Qin Y; Kaufman S; Oerline M; Vince R; Makarov D; Caram MV; Chapman C; Ravenell J; Hollenbeck BK; Skolarus TA
JCO Oncol Pract; 2023 May; 19(5):e763-e772. PubMed ID: 36657098
[TBL] [Abstract][Full Text] [Related]
16. Physician Dispensing Among Urology Practices and the Use of Abiraterone or Enzalutamide for Men With Advanced Prostate Cancer.
Lai LY; Kaufman SR; Oerline MK; Caram MEV; Maganty A; Hollenbeck BK; Shahinian VB
JNCI Cancer Spectr; 2022 Mar; 6(2):. PubMed ID: 35603854
[TBL] [Abstract][Full Text] [Related]
17. Understanding Active Surveillance for Prostate Cancer.
Lai LY; Shahinian VB; Oerline MK; Kaufman SR; Skolarus TA; Caram MEV; Hollenbeck BK
JCO Oncol Pract; 2021 Nov; 17(11):e1678-e1687. PubMed ID: 33830822
[TBL] [Abstract][Full Text] [Related]
18. Urologist Practice Affiliation and Intensity-modulated Radiation Therapy for Prostate Cancer in the Elderly.
Hollenbeck BK; Kaufman SR; Yan P; Herrel LA; Borza T; Schroeck FR; Jacobs BL; Skolarus TA; Shahinian VB
Eur Urol; 2018 Apr; 73(4):491-498. PubMed ID: 28823605
[TBL] [Abstract][Full Text] [Related]
19. Documenting Horizontal Integration Among Urologists Who Treat Prostate Cancer.
Mitchell JM; Gresenz CR
Med Care Res Rev; 2022 Feb; 79(1):141-150. PubMed ID: 33331217
[TBL] [Abstract][Full Text] [Related]
20. Urologist compliance with AUA best practice guidelines for benign prostatic hyperplasia in Medicare population.
Strope SA; Elliott SP; Saigal CS; Smith A; Wilt TJ; Wei JT;
Urology; 2011 Jul; 78(1):3-9. PubMed ID: 21601254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]